D. Caldirola, Italy

Humanitas University Mental Health
Dr. Caldirola (M.D., PhD) is a psychiatrist and researcher in psychiatry. She works at Humanitas University (Milan); Personalized Medicine Center for Anxiety and Panic Disorders, Humanitas San Pio X (Milan); and the Department of Clinical Neurosciences, Villa San Benedetto Menni, Hermanas Hospitalarias (Albese con Cassano, Como, Italy). The published several articles in international scientific journals. Her main fields of interest are the psychophysiology and psychopharmacology of psychiatric disorders, especially Anxiety Disorders. In particular, her research field is focused on the identification of biomarkers (diagnostic, prognostic, predictive) of Anxiety Disorders in the framework of evidence-based, personalized medicine approach to psychiatric disorders. In addition, Dr. Caldirola is interested in the study of comorbidity between mental and medical diseases, in terms of underlying mechanisms and impact on clinical symptoms and therapeutic outcomes.

Presenter of 2 Presentations

e-Poster Viewing (ID 1107) AS34. Psychoneuroimmunology

EPV0485 - C-reactive protein in a naturalistic sample of inpatients with Major Depressive Disorder, Bipolar Disorder and Obsessive-Compulsive Disorder

Session Name
e-Poster Viewing (ID 1107)
Date
Sun, 11.04.2021
Session Time
07:30 - 23:59
Room
e-Poster Gallery
Lecture Time
07:30 - 07:30

ABSTRACT

Introduction

The relevance of inflammation to psychiatric disorders is well established. While inflammation was broadly investigated in mood disorders, obsessive-compulsive disorder (OCD) received little attention. C-reactive protein (CRP) is an inflammatory marker commonly assessed in clinical practice. Studies comparing CRP levels across mood disorders and OCD are lacking.

Objectives

We compared the prevalence of CRP-based low-grade inflammation (LGI) across major depressive disorder (MDD), bipolar disorder (BD) and OCD, taking into account multiple individual variables that may affect CRP levels.

Methods

Retrospective, observational cross-sectional study in a naturalistic sample of hospitalized patients with MDD or BD or OCD. Information was collected from electronic medical records. Based on serum CRP levels at admission, the following were defined: CRP: >3 mg/L and ≤10 mg/l, “yes” LGI; ≤3 mg/L, “no” LGI. Logistic regression models were applied.

Results

We included 156 patients with MDD, 135 with BD, and 97 with OCD. We found prevalence rates of CRP-LGI of 29.9%, 36.5%, and 47.4% in patients with OCD, MDD, and BD, respectively, without significant differences between groups. The entire set of individual variables considered (e.g., sex, body mass index, medication) explained only one-third of the observed variations in CRP-LGI.

Conclusions

CRP-LGI may be a transdiagnostic feature of a substantial portion of patients with MDD or BD or OCD, rather than being exclusive to a specific psychiatric disorder. The presence of LGI was not fully explained by individual confounding factors. Given the relevance of inflammation to psychiatric and medical outcome, routine measurements of CRP in psychiatric settings may be valuable.

Hide
Oral Communications (ID 1110) AS07. COVID-19 and related topics

O074 - New onset of mental disorders, lifestyle changes, and quality of relationships during Covid-19 in Italian population.

Date
Sat, 10.04.2021
Session Time
07:00 - 21:00
Room
On Demand
Lecture Time
18:36 - 18:48

ABSTRACT

Introduction

The COVID-19 pandemic has been causing relevant public health and psychosocial consequences.

Objectives

To assess the impact of the COVID-19 pandemic on mental health, lifestyle and personal relationships in the Italian general population.

Methods

An online survey spread between May and June 2020 to collect socio-demographic, clinical, lifestyle, relationship, and mental health self-reported information. Mental disorder screening was performed by the Patient Health Questionnaire and PTSD Checklist for DSM-5.

Results

Participants were 2003, 1504 of which (75%) completed the entire questionnaire (1157 females, 77%). Among the completers who have not had any mental disorder before (n=524, 35%), 263 (51.7%) met cut-off scores for psychiatric diagnoses on the self-report psychiatric screeners during the pandemic (i.e., Major Depressive Disorder, 11.3%, with death thoughts in approximately half of the cases; Panic Disorder, 1.1%; Generalized Anxiety Disorder, 13%.3, Obsessive-Compulsive Disorder, 13.2%, Post-Traumatic Stress Disorder, 7.3%; Alcohol Abuse, 5.5%). In line with this, 39% of completers complained of insomnia, while 12% and 10% started using anxiolytics and antidepressants, respectively. Approximately 7-8 % of completers started/increased alcohol and/or nicotine consumption, 33% quitted/decreased physical activity, and 40% declared decreased sexual satisfaction. Approximately 21% and 38% declared worsening in relationship with partner and difficulty in child-caring, respectively.

Conclusions

The COVID-19 pandemic appears to be a risk factor for new onset of mental disorders and worsening in lifestyle and familial relationships in the Italian population. These results should be confirmed by clinical interviews, and may represent a starting point for further monitoring of the medium and long-term consequences of the COVID-19 pandemic.

Hide